Aki clinical trials

Explore recruiting aki clinical trials.

Recruiting aki studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Aki trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ARTEMIS: RAvulizumab to PRotect PaTients with Chronic Kidney DisEase (CKD) froM Cardiac Surgery Associated Acute Kidney Injury (CSA-AKI) and Subsequent Major Adverse Kidney Events (MAKE): A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study

Italy, Germany, Poland, Spain, Netherlands, France +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

LIVER AKI: A randomized, open-label trial to evaluate the efficacy of intravenous human albumin administration versus saline solution (NaCl 0.9%) in patients with decompensated cirrhosis and AKI 1B or grater.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

CLEAR-AKI: A multi-center, randomized, double blinded, placebo-controlled, four arm, parallel-group, dose-finding phase 2b study to investigate the safety and efficacy of TIN816 via a single intravenous infusion in the treatment of participants associated with sepsis- associated acute kidney injury (SA-AKI)

Germany, Austria, Czechia, Belgium, Italy, Hungary +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Modified autologous leukocyte cells for the treatment of acute kidney injury after cardiac surgery

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

proMoting Effective Renoprotection in Cardiac sURgery patients by Inhibition of SGLT-2

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

The effect of noradrenaline infusion versus standard blood pressure management on perioperative HYPotension in NOncaRdiac surgery.

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Aki trials by city

Aki in Toronto Aki in Vancouver Aki in Montreal Aki in Calgary Aki in Edmonton Aki in Ottawa Aki in Winnipeg Aki in Quebec City Aki in Hamilton Aki in Kitchener Aki in London Aki in Halifax Aki in New York Aki in Los Angeles Aki in Chicago Aki in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease